EFFICIENCY OF NEW IMMOBILIZED PROBIOTIC AS A PART OF TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS

The study was conducted in order to evaluate the efficiency of adding immobilized probiotic biologically active food supplement of LB-Complex L to integral treatment of pulmonary tuberculosis. Changes of colon microorganism community in pulmonary tuberculosis patients including those with multiple d...

Full description

Saved in:
Bibliographic Details
Main Authors: I. V. Belovа, I. V. Solovievа, A. G. Tochilinа, S. F. Bаrbolinа, A. V. Pаvlunin, A. S. Shprykov
Format: Article
Language:Russian
Published: New Terra Publishing House 2017-05-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1002
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849771800645337088
author I. V. Belovа
I. V. Solovievа
A. G. Tochilinа
S. F. Bаrbolinа
A. V. Pаvlunin
A. S. Shprykov
author_facet I. V. Belovа
I. V. Solovievа
A. G. Tochilinа
S. F. Bаrbolinа
A. V. Pаvlunin
A. S. Shprykov
author_sort I. V. Belovа
collection DOAJ
description The study was conducted in order to evaluate the efficiency of adding immobilized probiotic biologically active food supplement of LB-Complex L to integral treatment of pulmonary tuberculosis. Changes of colon microorganism community in pulmonary tuberculosis patients including those with multiple drug resistance were studied in two groups of patients: receiving only basic treatment and basic treatment with the immobolized probiotic of LB-Complex L as a food supplement. The algorithm of probiotic intake has been offered with the consideration of pharmacodynamics of anti-tuberculosis drugs. The offered algorithm proved to be effective for prevention of disorders in microorganism community, enhancement of adherence to treatment, reduction of frequency, severity and duration of side effects to anti-tuberculosis drugs.
format Article
id doaj-art-1c424f0dbd47449181bff29366dcb4c7
institution DOAJ
issn 2075-1230
2542-1506
language Russian
publishDate 2017-05-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj-art-1c424f0dbd47449181bff29366dcb4c72025-08-20T03:02:30ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062017-05-01955344010.21292/2075-1230-2017-95-5-34-401002EFFICIENCY OF NEW IMMOBILIZED PROBIOTIC AS A PART OF TREATMENT OF PULMONARY TUBERCULOSIS PATIENTSI. V. Belovа0I. V. Solovievа1A. G. Tochilinа2S. F. Bаrbolinа3A. V. Pаvlunin4A. S. Shprykov5I. N. Blokhina Nizhegorodsky Research Institute of Epidemiology and Microbiology, Nizhny NovgorodI. N. Blokhina Nizhegorodsky Research Institute of Epidemiology and Microbiology, Nizhny NovgorodI. N. Blokhina Nizhegorodsky Research Institute of Epidemiology and Microbiology, Nizhny NovgorodNizhegorodskaya State Medical Academy, Nizhny NovgorodNizhegorodskaya State Medical Academy, Nizhny NovgorodNizhegorodskaya State Medical Academy, Nizhny NovgorodThe study was conducted in order to evaluate the efficiency of adding immobilized probiotic biologically active food supplement of LB-Complex L to integral treatment of pulmonary tuberculosis. Changes of colon microorganism community in pulmonary tuberculosis patients including those with multiple drug resistance were studied in two groups of patients: receiving only basic treatment and basic treatment with the immobolized probiotic of LB-Complex L as a food supplement. The algorithm of probiotic intake has been offered with the consideration of pharmacodynamics of anti-tuberculosis drugs. The offered algorithm proved to be effective for prevention of disorders in microorganism community, enhancement of adherence to treatment, reduction of frequency, severity and duration of side effects to anti-tuberculosis drugs.https://www.tibl-journal.com/jour/article/view/1002pulmonary tuberculosismicroorganism communitydysbiosisimmobilized probiotic
spellingShingle I. V. Belovа
I. V. Solovievа
A. G. Tochilinа
S. F. Bаrbolinа
A. V. Pаvlunin
A. S. Shprykov
EFFICIENCY OF NEW IMMOBILIZED PROBIOTIC AS A PART OF TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS
Туберкулез и болезни лёгких
pulmonary tuberculosis
microorganism community
dysbiosis
immobilized probiotic
title EFFICIENCY OF NEW IMMOBILIZED PROBIOTIC AS A PART OF TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS
title_full EFFICIENCY OF NEW IMMOBILIZED PROBIOTIC AS A PART OF TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS
title_fullStr EFFICIENCY OF NEW IMMOBILIZED PROBIOTIC AS A PART OF TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS
title_full_unstemmed EFFICIENCY OF NEW IMMOBILIZED PROBIOTIC AS A PART OF TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS
title_short EFFICIENCY OF NEW IMMOBILIZED PROBIOTIC AS A PART OF TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS
title_sort efficiency of new immobilized probiotic as a part of treatment of pulmonary tuberculosis patients
topic pulmonary tuberculosis
microorganism community
dysbiosis
immobilized probiotic
url https://www.tibl-journal.com/jour/article/view/1002
work_keys_str_mv AT ivbelova efficiencyofnewimmobilizedprobioticasapartoftreatmentofpulmonarytuberculosispatients
AT ivsolovieva efficiencyofnewimmobilizedprobioticasapartoftreatmentofpulmonarytuberculosispatients
AT agtochilina efficiencyofnewimmobilizedprobioticasapartoftreatmentofpulmonarytuberculosispatients
AT sfbarbolina efficiencyofnewimmobilizedprobioticasapartoftreatmentofpulmonarytuberculosispatients
AT avpavlunin efficiencyofnewimmobilizedprobioticasapartoftreatmentofpulmonarytuberculosispatients
AT asshprykov efficiencyofnewimmobilizedprobioticasapartoftreatmentofpulmonarytuberculosispatients